ADHD and Autism Diagnoses Increasingly Include Children With Fewer Typical Risk Factors

Diagnostic Demographics Shift Over a Decade

A major study tracking more than 2.1 million Danish children and adolescents reveals a fundamental change in who receives ADHD and autism spectrum disorder diagnoses. Researchers from the Barcelona Institute for Global Health and Aarhus University analyzed 71,000 young people diagnosed with ADHD or ASD between 2012 and 2022, comparing them against 713,000 undiagnosed peers. The central finding: children and teenagers diagnosed in recent years increasingly resemble the general population, suggesting the rising diagnosis rate reflects not just more cases of these conditions, but a broadening of who gets identified and treated.

Narrowing of Classical Risk Factors

Historically, several characteristics have correlated strongly with ADHD and autism diagnoses—premature birth, low birth weight, parental psychiatric history, lower family income, and intensive prior healthcare use. The new research documents that these associations have weakened significantly over the past decade. Children born with low birth weight, for instance, were 54 percent more likely to receive an ADHD or ASD diagnosis at the study's start, but only 17 percent more likely by its end. Similar declines appeared across premature birth and various socioeconomic disadvantage measures. Crucially, the researchers emphasize that these risk factors remain relevant; the shift reflects changing diagnostic practice rather than the disappearance of meaningful associations.

Reframing the Diagnosis Increase Narrative

As ADHD and autism diagnoses have surged globally over the past decade, researchers typically investigate two questions: why are rates climbing, and which biological or social factors predict these conditions? This study flips the lens, asking instead whether the characteristics of diagnosed populations have themselves transformed. The answer appears to be yes, which carries significant implications for interpreting epidemiological trends. Rising diagnosis rates need not indicate a proportional rise in underlying disease prevalence; they may instead signal improved case-finding, expanded diagnostic access, heightened awareness, or shifting clinical thresholds for what constitutes meaningful impairment.

Multiple structural changes could drive this shift. Public and professional awareness of ADHD and autism has grown substantially. Healthcare and education systems may now identify cases that previously went unrecognized, particularly among children without obvious disadvantage markers. Diagnostic services may have expanded geographically or become more affordable. Clinical criteria or judgment about whether neurodevelopmental traits constitute a disorder warranting intervention may have evolved. The study cannot quantify each factor's contribution, but the data clearly show that the population now receiving diagnoses is broader and more representative of society overall.

Implications for Understanding Outcomes and Burden

The findings carry practical weight for healthcare planning, education policy, and social services. If the diagnosed population has changed composition, then comparisons of outcomes over time require careful interpretation. Some reports showing improved trajectories for people with ADHD or autism may partly reflect the inclusion of individuals with milder presentations or fewer comorbid complications, rather than actual improvements in disease course or treatment effectiveness. The research does not suggest overdiagnosis or lesser severity—only that the denominator of diagnosed cases now encompasses a wider range of presentations.

The researchers call for replication of these findings in other countries, as the study's Danish context may not fully generalize. Nevertheless, the work offers a more nuanced framework for policymakers and scientists navigating the sharp increase in neurodevelopmental diagnoses, one that avoids both dismissing rising rates as purely epidemiological artifact and uncritically accepting them as evidence of a population-wide surge in disease. The takeaway is simpler and more grounded: diagnosis reflects both the true occurrence of conditions and the criteria, awareness, access, and values that shape which individuals enter the healthcare system.